Journey Strategic Wealth LLC Adma Biologics, Inc. Transaction History
Journey Strategic Wealth LLC
- $2.71 Billion
- Q3 2024
A detailed history of Journey Strategic Wealth LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Journey Strategic Wealth LLC holds 15,040 shares of ADMA stock, worth $310,275. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,040Holding current value
$310,275% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
319Shares Held
185MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$385 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$374 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$268 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$260 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$177 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $4.05B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...